These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9874468)

  • 21. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors.
    Meaney CJ; Hynicka LM; Tsoukleris MG
    Pharmacotherapy; 2014 Jul; 34(7):653-61. PubMed ID: 24700598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and predictors of vancomycin-associated nephrotoxicity.
    Moh'd H; Kheir F; Kong L; Du P; Farag H; Mohamad A; Zurlo JJ
    South Med J; 2014 Jun; 107(6):383-8. PubMed ID: 24945176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
    Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
    Kralovicová K; Spanik S; Halko J; Netriova J; Studena-Mrazova M; Novotny J; Grausova S; Koren P; Krupova I; Demitrovicova A; Kukuckova E; Krcmery V
    J Chemother; 1997 Dec; 9(6):420-6. PubMed ID: 9491842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
    Dong MH; Wang JW; Wu Y; Chen BY; Yu M; Wen AD
    Int J Infect Dis; 2015 Aug; 37():125-8. PubMed ID: 26159843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between vancomycin-associated nephrotoxicity and the number of combined nephrotoxic agents.
    Ueki T; Sanematsu E; Furuya Y; Shinohara Y; Murakami Y; Miyazaki A; Sakamoto Y; Nakashima MN; Nakashima M
    Pharmazie; 2020 Jun; 75(6):279-283. PubMed ID: 32539926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
    Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
    Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure.
    Imai S; Yamada T; Kasashi K; Kobayashi M; Iseki K
    J Eval Clin Pract; 2017 Dec; 23(6):1240-1246. PubMed ID: 28544476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
    Barberan J; Mensa J; Artero A; Epelde F; Rodriguez JC; Ruiz-Morales J; Calleja JL; Guerra JM; Martínez-Gil I; Giménez MJ; Granizo JJ; Aguilar L
    Rev Esp Quimioter; 2019 Feb; 32(1):22-30. PubMed ID: 30630306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
    Rybak MJ; Albrecht LM; Boike SC; Chandrasekar PH
    J Antimicrob Chemother; 1990 Apr; 25(4):679-87. PubMed ID: 2351627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
    Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
    Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term vancomycin use had low risk of ototoxicity.
    Humphrey C; Veve MP; Walker B; Shorman MA
    PLoS One; 2019; 14(11):e0224561. PubMed ID: 31693679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-Treatment Serum C-Reactive Protein Level Is An Independent Risk Factor for Development of Nephrotoxicity in Patients Receiving High-Dose Vancomycin.
    He J; Mao EQ; Jing F; Jiang HT; Yang WH; Chen EZ
    Pharmacology; 2016; 97(5-6):294-300. PubMed ID: 26919511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous Vancomycin.
    Zasowski EJ; Murray KP; Trinh TD; Finch NA; Pogue JM; Mynatt RP; Rybak MJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin ototoxicity: a reevaluation in an era of increasing doses.
    Forouzesh A; Moise PA; Sakoulas G
    Antimicrob Agents Chemother; 2009 Feb; 53(2):483-6. PubMed ID: 19001107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia.
    Fullmer A; McCue D; Feng C
    J Oncol Pharm Pract; 2014 Dec; 20(6):403-8. PubMed ID: 24177356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
    Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
    Horey A; Mergenhagen KA; Mattappallil A
    Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.